Schedule 13G ownership disclosure
LYRA THERAPEUTICS INC
Security class unavailable · CUSIP: 55234L105
Event date: 2022-05-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,782,091
- Percent of class
- 8.7400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001590144-22-000025
- Form type
- SC 13G
- Filer
- Lyra Therapeutics, Inc.
- CIK
- CIK 1327273
- Filed
- Nov 08, 2022
- Reporting period
- May 20, 2022
- Description
- Schedule 13G beneficial ownership